New market report: custom oligo synthesis and the shift to nucleic acid drug CDMO
We have published a new market report on BioMarket.jp, our Japanese life science portal: Custom Oligo Synthesis Support Market: Business Opportunities in the Shift to Nucleic Acid Drug CDMO (in Japanese). Here is an overview.
Overview
Custom oligonucleotide synthesis has long been part of the research reagent business, supplying PCR primers, probes and synthetic gene fragments. Driven by the commercial success of nucleic acid drugs such as antisense oligonucleotides (ASOs) and siRNAs, the market is now shifting quickly toward contract development and manufacturing (CDMO).
Research oligos call for small quantities and fast turnaround. Drug manufacturing calls for kilogram-scale, cGMP-compliant production with tight impurity control. The two share a technology base but differ in capital needs, quality systems and customers, and the report reads the market through this two-tier structure.
Growth drivers
- Growing pipelines of chemically modified nucleic acids, including siRNA, ASO and guide RNA
- Target diseases widening from rare to chronic conditions
- Pharma companies outsourcing manufacturing as part of asset-light strategies
What the report covers
- Market overview, with market size estimated from several published sources
- The structural shift from research custom oligos to CDMO
- Competitive landscape and key players
- Regulatory trends and quality-related entry barriers
- Four opportunities for new entrants: specialty building blocks and modified amidites, advanced impurity analysis, sustainable synthesis processes, and conjugation and formulation support
- What public information cannot tell you, and what primary research should verify
The full report is available to BioMarket.jp members (free registration).
▶ Read the report on BioMarket.jp (in Japanese)
Researching this market in Japan
Public data says little about what Japanese researchers actually need and how they buy. BioSurvey asks Japanese life science researchers directly, so you can test demand and positioning before you commit. Contact us to discuss a study.